Also known as: Xi'An Aolitai Pharmaceutical Technology Co Ltd
Highest phase reached
Phase 2
First clinical trial
Last known activity
Aug 10, 2023
No events for the selected filters.
Phase 2 (1 own, 0 via acquisition)